Efficacy of continuous acyclovir infusion in neonatal herpes virus encephalitis.
We have successfully eliminated herpes simplex virus-2 from the central nervous system in a case of neonatal herpes simplex virus encephalitis with a continuous acyclovir infusion. A male infant delivered from a healthy 22-year-old woman without genital or systemic herpes symptoms around delivery began to develop fever and intractable seizures. He was started on intermittent intravenous acyclovir (20 mg/kg every 8 h) based on the diagnosis of herpes encephalitis. The virus was not eliminated with intermittent acyclovir and vidarabine, while continuous acyclovir was ultimately effective in eliminating herpes simplex virus from his central nervous system. This report demonstrates the efficacy of continuous acyclovir infusion in neonatal herpes simplex virus encephalitis.
Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan. kakisuke@mui.biglobe.ne.jp
Y
Y
Kakisaka
M
M
Ishitobi
K
K
Wakusawa
K
K
Haginoya
N
N
Togashi
T
T
Kitamura
N
N
Hino-Fukuyo
I
I
Sato
M
M
Uematsu
S
S
Tsuchiya
D000212:Acyclovir / Q000627:therapeutic use*; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D020803:Encephalitis, Herpes Simplex / Q000188:drug therapy* / Q000635:transmission; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D055815:Young Adult
D000998:Antiviral Agents; D000212:Acyclovir